News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma
Jan 29, 2025, 08:02

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma

Abdul Rahman Jazieh, Chief Executive Officer at Innovative Healthcare Institute, shared a post on Facebook:

“Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study”

Authors: Aung Naing, Amit Mahipal, Milind Javle, Judy Wang, Todd M. Bauer, David L. Bajor, Anthony D. Elias, Anthony Shields, Elizabeth Davis, Sant Chawla, Howard Safran, John D. Powderly, Gina D’Amato, Christian F. Meyer, Xiongwen Tang, Sheng Yao, Patricia Keegan

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma

Abdul Rahman Jazieh Amit Mahipal Anthony D. Elias Anthony Shields Aung Naing cancer Christian F Meyer David L. Bajor Elizabeth Davis Gina D’Amato Howard Safran John D. Powderly Judy Wang Milind Javle OncoDaily Oncology Patricia Keegan Sant Chawla Sheng Yao Todd M Bauer Xiongwen Tang
Special Coverage
Blog
May 21, 2025, 13:24
Dégi László Csaba: The European Commission Initiative on Cervical Cancer Working Group meeting at IARC
Insight
May 21, 2025, 13:17
Chris Boshoff: Pfizer Enters Licensing Agreement with 3SBio for Next-Gen Bispecific Antibody
Blog
May 21, 2025, 13:15
Lacy Hubbard: Elekta Foundation’s Progress Toward Cervical Cancer Elimination in Rwanda
Blog
May 21, 2025, 13:04
Call on Congress to Support Cancer Research - AACR
Blog
May 21, 2025, 12:59
E-Cigarette and Vaping Practices among U.S. Millennial Adults - Mount Sinai Department of Medicine
Oncolibrary
May 21, 2025, 12:55
Immunohistochemistry (IHC): How Antibodies Help Diagnose and Classify Disease
Blog
May 21, 2025, 12:50
Ahmed Magdy Rabea: Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma
Blog
May 21, 2025, 12:38
Heidi Ko: The Importance of Biomarker Testing HER2 in Cancer Care
Blog
May 21, 2025, 12:32
Oliver Bogler: NanCI Webapp to Support Scientists Using AI
Blog
May 21, 2025, 12:22
Vivek Subbiah: Honored to Work Alongside an Incredible Team of Investigators Dedicated to Ending Cancer
Blog
May 21, 2025, 12:16
Teresa Amaral: Honoring Clinical Research Teams on International Clinical Trials Day
Science
May 21, 2025, 12:14
Myeloma Paper of the Day, May 21st, suggested by Robert Orlowski